JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: BIIB021 (CNF2024; BIIB-021; CNF-2024; CNF 2024; BIIB 021) is an orally bioavailable and purine-based small-molecule inhibitor of HSP90 (heat shock protein 90) with potential anticancer activity. It inhibits HSP90 with a Ki and an EC50 of 1.7 nM and 38 nM, respectively. BIIB021 exhibits excellent in vivo antitumor efficacy in many tumor xenograft models such as N87, BT474, CWR22, U87, SKOV3 and Panc-1.
References: Mol Cancer Ther. 2009 Apr; 8(4):921-9; Clin Cancer Res. 2009 Aug 15; 15(16):5108-16; Int J Cancer. 2010 Mar 1; 126(5):1216-25.
Related CAS: 848695-25-0 (free base); 1225041-97-3 (mesylate)
C14H15ClN6O
Chemical Name: [6-Chloro-9-(4-methoxy-3, 5-dimethylpyridin-2-ylmethyl)-9H-purin-2-yl]amine
InChi Key: QULDDKSCVCJTPV-UHFFFAOYSA-N
InChi Code: InChI=1S/C14H15ClN6O/c1-7-4-17-9(8(2)11(7)22-3)5-21-6-18-10-12(15)19-14(16)20-13(10)21/h4, 6H, 5H2, 1-3H3, (H2, 16, 19, 20)
SMILES Code: NC1=NC(Cl)=C2N=CN(CC3=NC=C(C)C(OC)=C3C)C2=N1
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!